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Introduction 
In 1946, a series of 4(1H)-quinolone including endochin was discovered to be one of the first 
synthetic sets of compounds displaying antimalarial activity in avian models6. Likewise, 
acridines and acridine-based drugs have been known to confer antimalarial activity, since World 
War II, when the U.S. army took great strides to reduce causalities as a result of malaria7. 
Mechanistic studies have shown that some acridine-based compounds work by interacting and 
binding to heme to prevent it from crystallizing. This fact is important since the parasite stores 
heme as a food source8. Therefore, it is hypothesized that 1,2,3,4-tetrahydroacridones  (THA) as 
a hybrid of 4(1H)-quinolones and acridines, could display good inhibition against atovaquone-
susceptible and atovaquone-resistant P. falciparum isolates W2 and TM90-C2B. The core part of 
endochin is similar to that of atovaquone, except, endochin contains an aliphatic heptyl chain at 
the 3-position while atovaquone has a bicyclic ring system in its place.  Since atovaquone was a 
potent inhibitor of P. falciparum activity in the past9, and atovaquone has similar structural 
properties to endochin and ubiquinone (figure 1.1), incorporation of these features to the THA 
scaffold were envisioned as being the starting point for a structure activity relationship (SAR) as 
potential antimalarial agents (figure 1.2).  
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Figure 1.1: Structure of existing antimalarial agents: atovaquone,  endochin,  and acridine.  
 
 
Luong 2 
 
Figure 1.2: Structure of R-substituted 1,2,3,4-tetrahydroacridone, where R1=Cl-, MeO-, Me- and where X or Y= 
H- or Me- as a proposed antimalarial drug candidate. 
Plans to develop this hybrid came from pre-existing data which displayed acridine-based 
compounds as potent antimalarials. To further confirm the fact that THAs could be potent 
inhibitors of the mitochondrial bc1 complex, recent studies involving close relatives of 1,2,3,4- 
tetrahydroacridones (THA) such as acridinediones (differing from THAs primarily by a 
secondary ketone group) have shown inhibitory effects at low nanomolar concentration range. In 
fact, WR 249685, which is an acrididienone (figure 1.4), has been reported to have an inhibitory 
concentration that targets at half of the parasite activity (EC50 value) at about 3 nM10.  
      
Figure 1.4: Structure of the S enantiomer of WR 249685. This compound is an acridinedione and is structurally 
similar to the tetrahydroacridone. 
In order to develop the library, the THA structure-activity relationships were determined by 
following a known procedure. The Topliss operational scheme11 is followed by synthesizing 
different analogs containing electron withdrawing or donating functional groups such as Cl-, F-, 
NO2-, Me-, and MeO- and comparing biological activity to the unsubstituted molecule of 
interest.  
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Figure 1.5: Topliss operational scheme for aromatic substituents.  
As shown by the scheme, a Cl– substituent is first synthesized on the core compound (the THA) at the 4th position or 
R4 of the benezoid ring. Different substituents are created according to the activity of the Cl– substituent at R4.  If  
Cl– at R4 displays equal (E) activity to an unsubstituted THA, then the next step would be to add a –Me functional 
group to the core THA to test if this functional group has equal (E), more (M), or (L) less activity than the previous 
compound synthesized.  As a result, the THA library was expanded using this scheme. 
This stepwise schematic allows for researchers to determine how helpful the functional groups 
are in relation to the parent molecule’s activity.  The 1,2,3,4-tetrahydroacridones  containing 
different substituent groups are tested in vitro to determine if they would have an effect on 
atovaquone-susceptible and atovaquone-resistant P. falciparum isolates W2 and  TMC2B90, 
respectively.  
Results & Discussion 
Chemistry: The structure-activity relationship (SAR) began with the generation of 1,2,3,4-
tetrahydroacridone compounds employing commercially available anthranilic acid and various 
cycloalkanones, where R1-4 = H-, Cl-, Me-, or MeO-, and X,Y could be H- or Me-. Compounds 
(1a-12a, 1b-12b, 1c-12c, 5d-6d) synthesized by this POCl3 method faced harsh acidic 
conditions. However, no regioisomers were created through this route, as the intermediate 
enamine formed in the reaction can only form one product (Scheme 1). 
 
Scheme 1. POCl3 reaction using commercially available anthranilic acids. 
Luong 4 
 
OH
NH2
O
O
N
Cl
N
H
O
AcOH
Seal Tube
200oC / 2hr
i)
ii) POCl3
reflux, 2hrR1
R2
R3
R4
R1
R2
R3
R4
R1
R2
R3
R4
Purfied via flash chromatography Purfied via recrystallization
XX
Y
Y
X
X
Y
Y
Y
Y
X X
An 
intermediate 9-chloro-1,2,3,4-tetrahydroacridone was isolated via flash chromatography and then 
hydrolyzed via acetic acid in a sealed tube at 200oC which furnished the various 1,2,3,4-
tetrahydroacridone. These crude compounds were collected via filtration and then further 
purified via recrystallization from pyridine.  
In the following scheme, anilines were used as an alternative (due to unavailable anthranilic 
acids), from which THAs (1d-4d) could be produced using a Conrad-Limpach cyclization 
(Scheme 2). Aniline is refluxed at 110◦C with ethyl 2-oxocyclohexanecarboxylate, acetic acid, 
and benzene for 24 hours.  The crude material is then refluxed in biphenyl ether to attain the 
respective substituted THA. Molecules produced by this scheme produce regioisomers when 
meta-substituted anilines are used. 
Scheme 2. Conrad-Limpach Reaction using commercially available anilines. 
 
  
 
Structure-Activity Relationship (R1-4, X, Y). 
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Figure 1.6 THA Scaffold: This scaffold depicts the THA blueprint for which different substituents (Cl-, MeO-
, Me-) are attached at R1-4
 
positions. X,Y can be H- or Me-. 
The goal of this structure activity relationship is to gain insight to the types and on the positions 
of substituents that would give the most favorable drug-parasite interaction at the lowest 
inhibitory concentrations. This interaction is analyzed by measuring the drug’s EC50 against the 
parasite isolates. EC50 is required concentration induces a response halfway between the baseline 
and the maximum concentration after some specified exposure time. In other words, a drug’s 
EC50 allows for analysis of its potency. It is crucial that the drug shows interaction with both the 
atovaquone-susceptible and the atovaquone-resistant parasite isolates at small concentration 
ranges. If the THA only inhibits one of the susceptible or resistant parasite isolates, it signifies 
that either the drug is not that potent or that there is an increased possibility for drug resistance 
against malaria.  
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0.623
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7.901
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1.011
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Table 1.1: Structure Activity Relationship with Cl–, X, and Y. 
Table 1.1 shows that there is a relationship between the Cl- functional group and the THA at 
certain positions. Strong results were obtained when R3
 
is Cl-substituted, W2 is inhibited at 99 
nM while TM90-C2B is inhibited at 66 nM. In comparision, when Cl- is attached at R2
 
(where X 
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or Y= Me-), the inhibitory effect of the THA is not as strong. RI ratios for both compounds 2a 
and 3a are under 3, which support the fact that both compounds are potent against both parasite 
isolates.  
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Table 1.2: Structure Activity Relationship with Me–, X, and Y. 
Out of this data set, the lowest EC50 values result when R2 is Me- and when X, Y are H-. EC50 
values of 150 nM for W2 and 152 nM for TM90-C2B are observed for this compound. 
Compound 6b differs from compound 2b by containing dimethyls at the X positions. When 6b is 
compared against EC50 values from compound 2b, it is observed that compound 6b does not 
work well on the atovaquone-susceptible strain. As a result, it could be inferred that the dimethyl 
groups on compound 6b may hinder some sort of binding interaction between parasite and the 
drugs and are not very useful functional groups in the optimization of THAs. Like the Cl-
substituted THAs, when X or Y all contain dimethyl functional groups, inhibitory concentration 
only decreases by a little when compared to the normal, unsubstituted THA (table 1.4, 1d). Only 
the inductive electron donating effects from Me- substituted at the R2 position generated an 
effective inhibitory action against the parasite isolates.  
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0.381
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Table 1.3: Structure Activity Relationship with MeO–, X, and Y. 
Like the previously aforementioned Me- substituted THAs, methoxy (MeO-) substituted THAs 
displayed the lowest EC50 values (90 nM for W2 and 99 nM for TM90-C2B) when MeO- is in 
the R2 position and when X, Y are all H-, However, when the MeO- substituent is placed at the 
R2 position, and when X, Y are solely H-, this compound (2c) inhibits the parasites more 
effectively than when X or Y is dimethylated (compounds 6c and 10c). The increase in EC50 
value indicates that dimethyl substituents did not produce any increased activity. MeO- exhibited 
more inhibitory activity at the R2 position than at any other position. Consequently, it could be 
said that at the R2 position, the MeO- substituent’s inductive electron donating effects generated 
effective inhibitory action against the parasite isolates. 
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Table 1.4: Miscellaneous Structure Activity Relationship with NO2-, F-, and H- substituted at R1-4, and with X, Y 
as H or Me. Compounds 1d, 5d-6d, were synthesized via Scheme 1. Compounds 2d-4d were produced by Scheme 
2. Compound 7d was created using Scheme 3.  
Based on the findings in table 1.4, it is further hypothesized that electron withdrawing 
substituents such as NO2-, F- would have little to no effect on optimizing the THA inhibition 
against parasite activity when they are substituted at R1-4. It is believed that the NO2- and F- 
functional groups do not contribute as much inhibitory action as Cl- groups do, due to 
differences in structural properties and electronic properties. Structually, NO2- is larger and 
bulkier than Cl- , whereas F- is smaller in size than Cl-. This information is helpful in deciding 
what other electron withdrawing substituents work best to enhance THA activity. It can be seen 
from the data that the best electron withdrawing substituent cannot be too big or too small 
because it will affect the THAs ability to effectively inhibit parasite activity.                                               
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Electronic properties also play an important role in understanding why the F- and NO2- 
functional groups are have less of an inhibitory effect than the Cl- substituent against parasite 
activity. Differences in electronic properties are governed by the mesomeric or resonance effect. 
The resonance effect explains how different functional groups can be electron withdrawing, 
donating, or both based on the appropriate resonance structures.  Since it is known that Cl– is 
electron withdrawing, and slightly electron donating12, it is believed that the Cl- substituent 
confers some push-pull effect to the aromatic portion of the THA. In comparison to Cl-, NO2- is 
solely an electron withdrawing or pulling agent and does not contribute to a dual electronic effect 
like Cl-. Rather, NO2- tends to hold on to the resonating electrons contributed by the aromatic 
regions of the THA. Similarly, the F- substituent contributes more to an electron withdrawing 
effect since it is more electronegative than Cl- and tends to hold on to its electrons more. F- and 
NO2- have similar but varied withdrawing effects on the THA, but do not display of strong of an 
inhibitory effect as the Cl- functional group.  Therefore the F- and NO2 groups at R2 and R3 do 
not contribute to optimizing the THA compound. 
As results show, the THA depends on both electron withdrawing and donating groups to improve 
its inhibitory effects against parasite activity. In this miscellaneous group of compounds (Table 
1.4), 7-chloro-6-methoxy-1,2,3,4-tetrahydroacridin-9(10H)-one (7d) displayed the best 
inhibitory activity (31 nM for W2 and 24 nM for TM90-C2B). Since Cl- and MeO- work well 
individually, it was believed if they were put together, they would further enhance the inhibitory 
effect against parasite isolates W2 and TM90-C2B. Individually, compounds 3d (R3= NO2), 4d 
(R1=F), 5d (R1-4=H, X=Me), 6d (R=H, Y=Me) were not as active as 7d. In fact, it took medium 
to high concentrations of the respective F- and NO2-substituted THAs to inhibit one or both of 
the parasite isolates W2 and TM90-C2B’s activities. Similarly, unsubstituted THAs with Me- at 
X or Y positions also required great inhibitory concentrations to effectively decrease parasite 
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activity. Resistance indices for compounds 3d (RI: 8.34), 4d (RI: 5.44), 5d (RI: 5.5) were greater 
than 3, which support the fact that these THAs, in particular, are not effective against 
atovaquone-susceptible and atovaquone-resistant parasite isolates W2 and TM90-C2B.  
Conclusions. The eight most active compounds generated by following the Topliss series are 
shown below (table 1.5). Eight listed molecules (2a, 3a, 11a, 2c, 6c,10c, 2b, 6b)  except for  7-
chloro-6-methoxy-1,2,3,4,-tetrahydroacridin-9(10H)-one, were prepared by POCl3 acid catalyzed 
cyclizations of substituted anthranilic acids with various cycloalkanones (scheme 1) followed by 
acetic acid hydrolysis. The 7-chloro-6-methoxy-1,2,3,4,-tetrahydroacridin-9(10H)-one is 
synthesized by a synthetic aniline generated via a sodamide reaction which was then further 
subjected to Conrad Limpach conditions according to Scheme 3. Figures 1.6-1.14 show the 
respective 1H MNR of the eight best compounds. Figures 1.15-1.22 show the respective 13C 
NMR spectra. 
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Table 1.5: Molecules with the greatest inhibitory activities against W2 and TM90-C2B. 
The MeO- and the Cl- substituents at R2 and at R3 respectively had the best structural activity out 
of four possible positions. When the ortho R2 and R3 positions are filled by MeO– and Cl– 
respectively, even lower EC50 values results for W2 (31 nM) and TMC2B90 (24 nM). This 
compound is the best product so far since it displayed the greatest activity against atovaquone-
resistant TMCB90and atovaquone-susceptible W2 parasite isolates. This action is believed to be 
due to the mesomeric or resonance effect displayed by both the Cl– and MeO– functional groups. 
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It was hypothesized that when these substituents were combined, an optimal THA could be 
created to inhibit the parasite isolates TMC2B90 and W2’s activity more effectively. The 
hypothesis was confirmed to be correct. The THA was shown to have a synergistic effect in 
activity when R2 = MeO- and R3 = Cl-. The fact that the MeO– functional group acts as the 
electron donating agent and the Cl– substituent works simultaneously as both an electron 
withdrawing and donating agent most likely contributes to the THA’s synergistic effect. Without 
the electron pushing and pulling synergistic effect created by these two substituents, a higher 
inhibitory concentration would have to be used to inhibit 50% of the activity displayed by 
atovaquone-susceptible W2 and atovaquone-resistant TMC2B90 parasite isolates. When these 
substituted THAs are paired with dimethyl groups at X and Y, the inhibitory activity of the THA 
is not as great as unsubstituted X and Y THAs. This event reveals that dimethyl substitutents are 
not necessary for inhibiting parasite activity. In addition, it is found that positions R1 and R4 were 
less important in terms of activity as compared to positions R2 and R3. Di-substituted as well as 
aryl substituted (R2 and R3) THAs are in preparation for further studies. 
 
 
